Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.9300 (23.67%) ($4.5900 - $6.3300) on Thu. Sep. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.13% (three month average) | RSI | 59 | Latest Price | $5.9300(23.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 5.2% a day on average for past five trading days. | Weekly Trend | CAPR declines -3.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) BWX(43%) LQD(39%) MCHI(18%) ONLN(18%) IBUY(17%) | Factors Impacting CAPR price | CAPR will decline at least -4.565% in a week (0% probabilities). TBT(-38%) USO(-37%) DRIV(-17%) REMX(-13%) XLC(-12%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.565% (StdDev 9.13%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $5.1(16.27%) | 10 Day Moving Average | $4.93(20.28%) | 20 Day Moving Average | $5.25(12.95%) | To recent high | -39.6% | To recent low | 16.4% | Market Cap | $117m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |